PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Pulmonary and Critical Care Medicine, Daegu Catholic University Medical Center, Daegu, Korea.\', \'Division of Pulmonary and Critical Care Medicine, Kyungpook National University Chilgok Hospital, Daegu, Korea.\', \'Division of Pulmonology, Department of Internal Medicine, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea.\', \'Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.\', \'Division of Pulmonary and Critical Care Medicine, Daegu Fatima Hospital, Daegu, Korea.\', \'Division of Pulmonary and Critical Care Medicine, Yeungnam University Medical Center, Daegu, Korea. letact@yu.ac.kr.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3349/ymj.2020.61.9.826
?:hasPublicationType
?:journal
  • Yonsei medical journal
is ?:pmid of
?:pmid
?:pmid
  • 32882767
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.649
?:rankingScore_hIndex
  • 53
?:title
  • Use of Darunavir-Cobicistat as a Treatment Option for Critically Ill Patients with SARS-CoV-2 Infection.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all